P/E ratio for UnitedHealth (UNH)
P/E ratio as of May 2023 (TTM): 22.0
According to UnitedHealth's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.0071. At the end of 2021 the company had a P/E ratio of 27.4.
P/E ratio history for UnitedHealth from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 27.4 | 26.79% |
| 2020 | 21.6 | 7.13% |
| 2019 | 20.2 | 0.88% |
| 2018 | 20.0 | -1.06% |
| 2017 | 20.2 | -4.08% |
| 2016 | 21.1 | 9.24% |
| 2015 | 19.3 | 10.82% |
| 2014 | 17.4 | 29.85% |
| 2013 | 13.4 | 33.57% |
| 2012 | 10.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Centene CNC | 23.3 | 6.03% | 🇺🇸 USA |
 Cigna CI | 11.2 | -49.12% | 🇺🇸 USA |
 Humana HUM | 20.3 | -7.75% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.